Diabetes CME

For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education.  Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease.  It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications.  

Worth 6.25 AMA PRA Category I Credits™, this enduring material is designed for primary care physicians, endocrinologists, diabetes educators, nurses, nurse practitioners, physician assistants and dietitians, with NO POST TEST.  Additionally, physicians can earn up to 6.25 ABIM MOC points for this activity. 

Pre-Order Today!
Discover the Latest Endocrinology Updates with Online CME

Cleveland Clinic’s Intensive Review of Endocrinology and Metabolism will help you prepare for the endocrine board certification examination with case-based continuing medical education sessions and high-yield board simulations focused on the latest developments and treatment methodologies. The quality and breadth of content is also ideal as a comprehensive review for both practicing endocrinologists and those with an interest in endocrinology, metabolism, and diabetes. CME topics include:

• Genetics and Endocrinology
• Cushing’s and Adrenal Insufficiency
• Case Management Studies in Endocrine Surgery
• Pediatric Endocrinology Case Reviews
• Osteoporosis and Vitamin D Deficiency
• Metabolic Bone Disease: Board Simulation
• Board Simulation Potpourri
• Advanced Lipidology
• and more…

Continuing Medical Education: Advances in Endocrinology

This online CME course in endocrinology is extremely thorough, covering a range of key topics and core concepts in the specialty. The Brigham Board Review in Endocrinology includes case-based lectures on a range of practice improvement areas, including adrenal, bone health and osteoporosis, cardiovascular endocrinology, diabetes, obesity, and thyroid. It’s endocrinology CME will help you to better:

• Integrate and demonstrate increased overall knowledge of endocrine diseases
• Identify and improve knowledge and clinical competence-based practice gaps
• Correlate pathophysiology and pathobiologic principles with clinical presentations
• Describe optimal therapeutic strategies and their risks and benefits
• Apply the knowledge and strategies gained to the board exam and daily practice

Learning Objectives

After viewing this activity, participants should be able to affirm or modify their approach to patient management in the following areas:

• Integrate and demonstrate increased overall knowledge of endocrine diseases
• Identify and improve knowledge and clinical competence-based practice gaps in endocrinology
• Correlate pathophysiology and pathobiologic principles with clinical presentations
• Describe optimal therapeutic strategies and their risks and benefits
• Apply the knowledge and strategies gained through participation in this activity to the board exam and daily practice

Intended Audience

This activity was designed for fellows/trainees and practicing endocrinologists and other professional affiliates (internists with an interest in endocrinology) who are preparing to become board certified, maintaining their certification, or who seek CME in attempt to improve patient care.

SiMCare Diabetes is a breakthrough method for clinician education. As an interactive online learning tool using patient-case simulation, SiMCare Diabetes delivers education where and when it is needed.

SiMCare Diabetes is designed to meet the following education objectives:
• Accurately diagnose type 1 or type 2 diabetes, hypertension, dyslipidemia and obesity.
• Adjust medication to achieve individualized care goals for blood sugars, A1C, blood pressure, LDL.
• Appropriately recommend patient self-monitoring of blood glucose (SMBG) testing.
• Provide accurate referral for specialty care.
• Identify diabetes-related comorbidities such as depression and hypoglycemia unawareness.

Target Audience:
Primary care physicians, physician assistants, nurse practitioners, pharmacists, dietitians and diabetes educators.

Topics covered in Intensive Review of Endocrinology and Metabolism include:
Adrenal Dysfunction, Menopause, Thyroid Nodules and Cancer, Male Hypogonadism and Infertility, Endocrine Surgery, Obesity, Diabetes Therapeutics: From New Insulins to Incretins, Female Hypogonadism, Pituitary Disorders, Metabolic Bone Disease and many more.

Studying Intensive Review of Endocrinology and Metabolism will help you to:
• Prepare for the ABIM endocrinology board exams
• Identify and effectively manage endocrine disorders in patients of varying ages
• Apply new information to everyday endocrinology care, improving diagnostic accuracy and management decisions
• Analyze the impact of endocrine disorders on women’s health, including pregnancy
• Appraise the management of osteoporosis and suggest effective preventive measures in diabetic care

The Evolution of Insulin Replacement Therapy consists of 4 presentations with discussion:
• Session 1: Insulin Options for Diabetes: Update on their Evolution
• Session 2: Advancing to Insulin Therapy for Type 2 Diabetes: The Impact of the New Insulin Options
• Session 3: Physiologic Insulin Replacement: Practical Approaches for the Primary Care Provider
• Session 4: The Evolution of Glycemic Monitoring and Insulin Delivery Devices: Why the Primary Care Provider Should Understand the Options

At the conclusion of The Evolution of Insulin Replacement Therapy, you will be able to:
• Identify clinically relevant pharmacokinetic and pharmacodynamic properties of the new insulins and insulin combinations
• Discuss the clinical importance of similarities and differences between a biosimilar insulin and a reference insulin
• Recognize the indications for advancement to insulin replacement therapy for people with T2DM
• Identify clinically relevant pharmacokinetic and pharmacodynamic properties of the new insulins and insulin combinations
• Describe initiation and titration methods for new insulin-based therapies to optimize achievement of glycemic goals while minimizing adverse effects
• Discuss strategies to overcome patient and clinician barriers to the successful initiation and utilization of insulin therapy in the context of the new insulin-based therapies, and monitoring and delivery devices

Target Audience:
This program is intended for US-based primary care providers, clinical endocrinologists/diabetologists, nephrologists, cardiologists, emergency department specialists, pharmacists, and other clinicians caring for patients with type 2 diabetes mellitus (T2DM).